Champix® is back: varenicline is back in pharmacies Good news for smokers motivated to quit their last cigarette for good: Champix® (varenicline) is back on the French market. Pfizer has announced that this molecule indicated for smoking cessation will be made available from mid-June 2025. A long-awaited reintroduction, both by health professionals and by nicotine-dependent patients who have failed with other approaches. One more option in the anti-smoking arsenal Indicated in adult smoking cessation, Champix® is a second-line treatment in the therapeutic strategy, after nicotine replacement therapy. In 2021, problems with impurities (presence of nitrosamines) led to a suspension of distribu... [Read more]